Cystic fibrosis drugs target the malformed proteins at the root of the disease

New combinations of molecules put many patients on the path to good health. But those with rarer mutations are, for now, left behind. New combinations of molecules put many patients on the path to good health. But those with rarer mutations are, for now, left behind.